Ambev (NYSE: ABEV) revenue
Ambev reported revenue of BRL 88,243m for fiscal 2025, 1.4% less than in fiscal 2024 (BRL 89,453m). Since fiscal 2016 its revenue has grown by 93.5%, an average growth of 7.6% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | BRL 88,243m | −1.4% | BRL 23,318m | 26.4% |
| 2024 | BRL 89,453m | +12.2% | BRL 21,802m | 24.4% |
| 2023 | BRL 79,737m | 0.0% | BRL 18,831m | 23.6% |
| 2022 | BRL 79,709m | +9.4% | BRL 17,688m | 22.2% |
| 2021 | BRL 72,854m | +24.8% | BRL 17,080m | 23.4% |
| 2020 | BRL 58,379m | +12.3% | BRL 15,972m | 27.4% |
| 2019 | BRL 52,005m | +3.5% | BRL 16,075m | 30.9% |
| 2018 | BRL 50,231m | +4.9% | BRL 17,151m | 34.1% |
| 2017 | BRL 47,899m | +5.0% | BRL 16,552m | 34.6% |
| 2016 | BRL 45,603m | — | BRL 17,105m | 37.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.
Questions about the revenue of Ambev
- How much revenue did Ambev make in fiscal 2025?
- Ambev reported revenue of BRL 88,243m for fiscal 2025, compared with BRL 89,453m in fiscal 2024.
- How much has the revenue of Ambev grown?
- Between fiscal 2016 and fiscal 2025 it went from BRL 45,603m to BRL 88,243m: 93.5% more, an average growth of 7.6% a year.
- What was the best year for revenue at Ambev?
- Of its last 10 fiscal years, fiscal 2024, with BRL 89,453m.
- Where do the figures for Ambev come from?
- From the annual report (Form 20-F) that Ambev files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 20-F) that Ambev files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ambev: the Ambev page · annual accounts · net income.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.